Fogarty Innovation

03/23/2026

Did you ever wish you could think faster and talk smarter? Especially when you need to speak up spontaneously? Tomorrow is your chance to learn from the master - Matt Abrahams, lecturer at Stanford University Graduate School of Business, author and podcast host! Join us from 12:30 - 2pm at Fogarty Innovation (includes lunch), or on Zoom (lunch is on you).

Email fogarty-education@fogartyinnovation.org by 4:00pm today to join us in person, or by 10am tomorrow to join us online! We can't wait to learn with you!

03/19/2026

"Tom dedicated his life to improving patient care. As a cardiovascular surgeon, a gifted engineer, and a relentless innovator, he transformed medicine. He reshaped surgical practice. He saved and improved the lives of millions around the world. And perhaps most powerfully, he inspired generations of innovators to keep asking the question he never stopped asking: Is there a better way?"
- Andrew Cleeland

Thank you, team LSI, for honoring Dr. Fogarty at the LSI USA '26 Emerging Medtech Summit this week. Your kind, t

03/18/2026

Mayo Clinic’s "Hospital of the Future" was the topic of a provocative Lunch & Learn last week. Leaders Peter Noseworthy, MD and Sanjay Bagaria, MD joined us to discuss Mayo's $6B investment to transform its physical infrastructure across campuses, and the accompanying opportunities for medtech companies to partner with them in new ways. Some takeaways:

➡️ Care will increasingly start at home.
Mayo is moving toward a model where patient care begins remotely, long before a patient arrives on campus. The goal is to blur the boundaries between digital and physical care, inpatient and outpatient care, and hospital and home, so that care is longitudinal and visits are coordinated and highly efficient once patients arrive.

➡️ Hospital rooms are becoming “smart” care environments.
At Mayo’s Jacksonville campus, hospital rooms include sensors, computer vision, and displays connected to the EMR that improve patient safety and help patients understand their medications, tests, and daily care plans. The physical design deliberately fades all of this technology into the background, so the focus is on the interaction between patient and clinician.

➡️ Healthcare delivery is becoming distributed.
Through its Mayo Clinic Beyond Walls program, Mayo is delivering hospital-level services in patients’ homes, enabled by a network of local care delivery partners. This approach will be increasingly used for consultative work (as opposed to surgical and procedural care), enabled by technology and made more actionable by leveraging data in new ways, like applying AI algorithms to ECG data for new insights.

After the presentation, our CEO Andrew Cleeland led an even wider-ranging discussion that explored structural forces reshaping healthcare and the challenge of integrating rapidly advancing technologies without losing the human elements of care.

Thanks to all for a meaningful conversation!

03/18/2026

03/15/2026

We're excited to announce the keynotes for our April 22, 2026 virtual event. Join us for fast-paced one-on-one mentoring sessions and quick keynotes from:

⭐️ Nada Hanafi, Co-founder, MedTech Color
⭐️ Matt Hillebrenner, Director of Government Affairs, Fogarty Innovation
⭐️ Howard Rosen, CEO & Co-founder, Evident Vascular

Seats fill up fast, so reserve your spot as a mentor or mentee now: https://hubs.li/Q045PLGX0

03/09/2026

Welcome! Maguro Surgical Inc., a startup founded by urologists and scientists at Stanford University, has joined Fogarty Innovation’s Company Accelerator Program (CAP). The company is developing a first-of-its-kind magnetic retrieval device for endoscopic kidney stone fragment removal. Its groundbreaking technology—the MagStone System—deploys a magnetic coating to magnetize the individual stone fragments and then retrieves the fragments with a specialized wire with a magnetic tip.

Maguro Surgical is a graduate of Fogarty’s Invention Accelerator Program (IAP). During the program, IAP director John Morriss supported the team in developing a regulatory strategy, identifying suppliers, and testing their value proposition within the medical community. Reflecting on the experience, founder and CEO, Dr. Kunj Sheth, observed, “Our time in IAP helped shift our mindset from an academic endeavor to a commercially viable opportunity that can meaningfully improve patient care.”

At Fogarty, the Maguro team will focus on accelerating their preclinical work to reach first-in-human studies while also completing the close of their $4 million seed round. CAP is a six-month program for early-stage companies designed to help them achieve specific objectives within their broader business plan.

The Maguro Surgical team includes Daniel Massana Roquero, PhD, founder and director of R&D; Eric Johnson, principal engineer; Jon-Michael Knapp, PhD, chief of staff; Jessie Ge, MD, founder and consulting director of regulatory strategy; and Joseph Liao, MD, founder and consulting director of clinical affairs. Thomas Cutro, a masters student at Stanford School of Engineering, is also working with the team.

03/04/2026

What does it take for innovative health technologies to succeed globally? This week in Tokyo, Fogarty Chief Commercial Strategy Officer Marga Ortigas-Wedekind and CMO Zachary Edmonds, MD, MBA joined leaders from across academia, startups, and industry at Japan Biodesign Tokyo　東京大学ジャパン・バイオデザイン Healthtech Innovation Day 2026, to discuss scaling to global markets and share Fogarty’s track record of high-touch programs that nurture global innovators. Zach and Marga also enjoyed a tour of the impressive hospital at The University of Tokyo / UTokyo!

03/03/2026

Welcome! AVaTAR MedTech, led by co-founder and CEO Tomás Armendariz Armendariz and co-founder and CSO Ignacio Lugones, MD, has joined Fogarty Innovation’s Company Accelerator Program (CAP). The company is taking aim at valvular heart disease, combining a novel surgical method and set of innovative medical devices to enable aortic or pulmonary valve reconstruction using autologous tissue.

The approach was pioneered by Lugones, a pediatric and congenital cardiac surgeon, who sought to address limitations in valve reconstruction options for children. Currently, procedures for pediatric patients are complicated by a lack of appropriately sized valves and children’s natural, rapid growth. AVaTAR’s approach also has applications for adults.

CAP is a six-month program designed to help early-stage companies achieve specific objectives within their broader business plan. AVaTAR MedTech is participating as part of Fogarty Innovation’s partnership with the UCSF-Stanford Pediatric Device Consortium, in which Fogarty supports pediatric device startups by providing four in-depth physicals annually and selecting one company for a longer collaboration.

The UCSF-Stanford Pediatric Device Consortium aims to improve pediatric health by accelerating the development of high-value pediatric device technologies across the product lifecycle. The program is funded by the FDA Office of Orphan Products Development.

03/03/2026

Why do managers from companies like Fogarty Innovation, Imperative Care, Longitude Capital, Pulmonx, Shifamed, Shockwave Medical, and Triple Ring Technologies send their interns to the DxD HealthTech Exploration Workshop?

Find out how this immersive, two-day experience hosted at Fogarty Innovation adds value to your summer internship program and sets your interns up for long-term success in the industry.

Company Info Session:
🗓️ Tuesday, March 17, 2026
🕛 Noon PT
💻 Online

Register: https://fogartyinnovation-org.zoom.us/meeting/register/3qTkEDmIQM2u7d632BJw1g?_x_zm_rtaid=pQca2x54QMuj1RRvLlzGhg.1770675643423.fa16ce161c8a54d0a46601fa9979d52a&_x_zm_rhtaid=230 #/registration